Ranking · Unmet Need
Research Gap Index
Burden percentile minus research-activity percentile (publications, last 5 years) within the same scope. Positive values flag cancers with high mortality burden but comparatively little literature. Caveat (Phase 1): literature counts are query-based per entity (query stored on each row); they are not aggregated over descendants.
Computedci-research-gap-v1unit: percentile pointshigher = worseAll metrics
| Rank | Δ | Cancer | Research Gap Index (percentile points) | Percentile | Confidence | Sources | Why #n? |
|---|---|---|---|---|---|---|---|
| 1 | = | Malignant Uterine Corpus Neoplasm | +70.4 | 100 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2608313 |
| 2 | = | Malignant Central Nervous System Neoplasm | +63 | 96.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2608314 |
| 3 | ▲2 | Malignant Kidney Neoplasm | +14.9 | 92.6 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2608316 |
| 3 | ▲4 | Multiple Myeloma | +14.9 | 92.6 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2608315 |
| 5 | ▲1 | Malignant Colon Neoplasm | +14.8 | 85.2 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2608317 |
| 6 | ▲2 | Malignant Liver Neoplasm | +14.8 | 81.5 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2608319 |
| 6 | ▲2 | Malignant Pancreatic Neoplasm | +14.8 | 81.5 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2608318 |
| 6 | ▼3 | Malignant Vulvar Neoplasm | +14.8 | 81.5 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2608320 |
| 9 | ▲1 | Non-Hodgkin Lymphoma | +11.1 | 70.4 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2608321 |
| 10 | ▼6 | Malignant Vaginal Neoplasm | +7.4 | 66.7 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2608322 |
| 11 | ▲5 | Malignant Lung Neoplasm | +3.7 | 63 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2608323 |
| 11 | ▲4 | Malignant Ovarian Neoplasm | +3.7 | 63 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2608324 |
| 13 | ▲1 | Malignant Rectal Neoplasm | +3.7 | 55.6 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2608325 |
| 14 | ▼2 | Malignant Anal Neoplasm | 0 | 51.9 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2608326 |
| 15 | ▼2 | Malignant Salivary Gland Neoplasm | -3.7 | 48.1 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2608327 |
| 16 | ▲5 | Malignant Breast Neoplasm | -3.7 | 44.4 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2608328 |
| 17 | = | Cutaneous Melanoma | -7.4 | 40.7 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2608329 |
| 18 | ▼1 | Malignant Laryngeal Neoplasm | -7.4 | 37 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2608330 |
| 19 | ▲3 | Leukemia | -11.1 | 33.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2608331 |
| 20 | ▲4 | Malignant Esophageal Neoplasm | -11.2 | 29.6 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2608332 |
| 21 | ▲6 | Malignant Mesothelioma | -14.8 | 25.9 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2608333 |
| 22 | ▼5 | Malignant Hypopharyngeal Neoplasm | -14.8 | 22.2 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2608334 |
| 23 | = | Malignant Nasopharyngeal Neoplasm | -18.5 | 18.5 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2608335 |
| 24 | ▲4 | Malignant Bladder Neoplasm | -18.5 | 14.8 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2608336 |
| 25 | ▲5 | Hodgkin Lymphoma | -25.9 | 11.1 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2608337 |
| 26 | ▲7 | Malignant Thyroid Gland Neoplasm | -29.7 | 7.4 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2608338 |
| 27 | ▲6 | Malignant Cervical Neoplasm | -40.8 | 3.7 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2608339 |
| 28 | ▲7 | Malignant Gastric Neoplasm | -44.5 | 0 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2608340 |
Data updated 16 hours agoSource updated unknown28 eligible entities · inputs hash 757e13b7eae18f0fcf461547